News
Dr. Reddy’s and TR-Pharm Announce Strategic Collaboration in Turkey
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and TR-Pharm announced today a strategic collaboration agreement involving 3 biosimilar products. A total...
Press Releases
ANI Pharmaceuticals and Dexcel Announce FDA Approval of Donepezil Hydrochloride 23mg Tablets
ANI Pharmaceuticals, Inc. (“ANI”) (NASDAQ: ANIP) today announced that its collaboration partner Dexcel Pharma Technologies Ltd. (“Dexcel”) has received approval from the U.S. Food...
Press Releases
Abbott’s Absorb™, the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee
Abbott announced that an independent panel of experts convened by the U.S. Food and Drug Administration (FDA) voted 9 to 0, with one abstention,...
News
Lundbeck starts clinical phase III program with Lu AF35700
H. Lundbeck A/S announced that the investigational compound Lu AF35700, a novel antipsychotic, is entering clinical phase III program. Lundbeck is...
Press Releases
OncoQR ML GmbH and TYG Oncology, Ltd Expand their Collaboration Against Cancers
TYG oncology, a UK biotechnology company specializing in hormone neutralization therapy for gastrointestinal cancers, and OncoQR ML GmbH, an Austrian biotechnology company specializing in...
Press Releases
The Health Industry Summit stirs investor frenzy over China’s healthcare sector with double-digit growth
In the summer of 2015, an event drew record-breaking single-day crowds of over 170,000 professionals to Shanghai solely for the healthcare sector. It was...
Research Insight
Studies Show Ixekizumab Improved Work Productivity for Patients with Moderate-to-Severe Plaque Psoriasis
Eli Lilly and Company announced that JAMA Dermatology has published detailed results from three pivotal Phase 3 trials that evaluated the effect of ixekizumab...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read